Kumar R - Search Results

1

Tolvaptan and Number Needed to Harm in Autosomal Dominant Polycystic Kidney Disease.

Betts KA, Nunna S, Kumar R, Nie X, Fernandes AW. Betts KA, et al. Among authors: kumar r. Kidney Med. 2024 Feb 20;6(4):100802. doi: 10.1016/j.xkme.2024.100802. eCollection 2024 Apr. Kidney Med. 2024. PMID: 38562967 Free PMC article. No abstract available.

2

Liver safety of tolvaptan in patients with autosomal dominant polycystic kidney disease: interim data from a post-authorization safety study.

Jaeger T, Lohrmann E, Ezenekwe A, Enekebe K, Kumar R, Nunna S, Fernandes AW, McCormick L, George V. Jaeger T, et al. Among authors: kumar r. Clin Kidney J. 2024 Oct 30;17(11):sfae324. doi: 10.1093/ckj/sfae324. eCollection 2024 Nov. Clin Kidney J. 2024. PMID: 39530110 Free PMC article.

3

International Variability in the Epidemiology, Management, and Outcomes of CKD and ESKD: A Systematic Review.

Freedberg DE, Segall L, Liu B, Jacobson JS, Mohan S, George V, Kumar R, Neugut AI, Radhakrishnan J. Freedberg DE, et al. Among authors: kumar r. Kidney360. 2024 Jan 1;5(1):22-32. doi: 10.34067/KID.0000000000000335. Epub 2023 Dec 6. Kidney360. 2024. PMID: 38055708 Free PMC article.

4

Enhancing the Efficiency of the Individual Case Safety Report (ICSR) Quality and Compliance through Automation.

Link S, Kammler A, Gupta R, Hembade M, Kumar R, George V. Link S, et al. Among authors: kumar r. Curr Drug Saf. 2024;19(2):255-260. doi: 10.2174/1574886318666230801162002. Curr Drug Saf. 2024. PMID: 37533250

5

Efficacy of repetitive transcranial magnetic stimulation for phantom limb pain- a meta analysis of randomized controlled trials.

Chandni F, Savanti F, Kumar R, Raj M, Kumar A, Kumar A, Kinger S, Kumar S, Rai H, Shaik AA, Asghar MS. Chandni F, et al. Among authors: kumar r. Neurol Sci. 2025 Jan 23. doi: 10.1007/s10072-025-08016-x. Online ahead of print. Neurol Sci. 2025. PMID: 39849176 Review.

6

False-Positive FAPI Expression in Benign Breast Adenosis.

Gunasekaran V, Subrhamanian A, Ambalavanan N, Singh H, Kumar R, Mittal BR, Shukla J, Walia R, Mitra S. Gunasekaran V, et al. Among authors: kumar r. Clin Nucl Med. 2025 Jan 20. doi: 10.1097/RLU.0000000000005664. Online ahead of print. Clin Nucl Med. 2025. PMID: 39848221

7

Retraction Note: Early diagnosis of COVID-19-affected patients based on X-ray and computed tomography images using deep learning algorithm.

Dansana D, Kumar R, Bhattacharjee A, Hemanth DJ, Gupta D, Khanna A, Castillo O. Dansana D, et al. Among authors: kumar r. Soft comput. 2024;28(Suppl 1):67. doi: 10.1007/s00500-024-09993-5. Epub 2024 Jul 22. Soft comput. 2024. PMID: 39847670 Free PMC article.

8

1,2,3-Triazole-tethered fluoroquinolone analogues with antibacterial potential: synthesis and in vitro cytotoxicity investigations.

Patel UK, Alka, Tiwari P, Tilak R, Joshi G, Kumar R, Agarwal A. Patel UK, et al. Among authors: kumar r. RSC Adv. 2025 Jan 22;15(3):1896-1914. doi: 10.1039/d4ra08643k. eCollection 2025 Jan 16. RSC Adv. 2025. PMID: 39845107 Free PMC article.

9

Healthcare worker views on antimicrobial resistance in chronic respiratory disease.

Ananth S, Adeoti AO, Ray A, Middleton PG, Ekkelenkamp M, Thee S, Shah A; AMR-Lung Clinical Research Collaboration. Ananth S, et al. Antimicrob Resist Infect Control. 2025 Jan 22;14(1):1. doi: 10.1186/s13756-025-01515-8. Antimicrob Resist Infect Control. 2025. PMID: 39844291

10

Advances and Challenges in the Diagnosis of Leishmaniasis.

Mehrotra S, Tiwari R, Kumar R, Sundar S. Mehrotra S, et al. Among authors: kumar r. Mol Diagn Ther. 2025 Jan 22. doi: 10.1007/s40291-024-00762-6. Online ahead of print. Mol Diagn Ther. 2025. PMID: 39843806 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

19,585 results

Search Page

Filters